These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

2465 related articles for article (PubMed ID: 24476820)

  • 21. Programmable DNA cleavage in vitro by Cas9.
    Karvelis T; Gasiunas G; Siksnys V
    Biochem Soc Trans; 2013 Dec; 41(6):1401-6. PubMed ID: 24256227
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Phylogeny of Cas9 determines functional exchangeability of dual-RNA and Cas9 among orthologous type II CRISPR-Cas systems.
    Fonfara I; Le Rhun A; Chylinski K; Makarova KS; Lécrivain AL; Bzdrenga J; Koonin EV; Charpentier E
    Nucleic Acids Res; 2014 Feb; 42(4):2577-90. PubMed ID: 24270795
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Inhibition Mechanism of an Anti-CRISPR Suppressor AcrIIA4 Targeting SpyCas9.
    Yang H; Patel DJ
    Mol Cell; 2017 Jul; 67(1):117-127.e5. PubMed ID: 28602637
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Coordinated Actions of Cas9 HNH and RuvC Nuclease Domains Are Regulated by the Bridge Helix and the Target DNA Sequence.
    Babu K; Kathiresan V; Kumari P; Newsom S; Parameshwaran HP; Chen X; Liu J; Qin PZ; Rajan R
    Biochemistry; 2021 Dec; 60(49):3783-3800. PubMed ID: 34757726
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Type I-E CRISPR-cas systems discriminate target from non-target DNA through base pairing-independent PAM recognition.
    Westra ER; Semenova E; Datsenko KA; Jackson RN; Wiedenheft B; Severinov K; Brouns SJ
    PLoS Genet; 2013; 9(9):e1003742. PubMed ID: 24039596
    [TBL] [Abstract][Full Text] [Related]  

  • 26. C2c1-sgRNA Complex Structure Reveals RNA-Guided DNA Cleavage Mechanism.
    Liu L; Chen P; Wang M; Li X; Wang J; Yin M; Wang Y
    Mol Cell; 2017 Jan; 65(2):310-322. PubMed ID: 27989439
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of CRISPR-Cas9 genome interrogation in living cells.
    Knight SC; Xie L; Deng W; Guglielmi B; Witkowsky LB; Bosanac L; Zhang ET; El Beheiry M; Masson JB; Dahan M; Liu Z; Doudna JA; Tjian R
    Science; 2015 Nov; 350(6262):823-6. PubMed ID: 26564855
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CRISPR/Cas9 searches for a protospacer adjacent motif by lateral diffusion.
    Globyte V; Lee SH; Bae T; Kim JS; Joo C
    EMBO J; 2019 Feb; 38(4):. PubMed ID: 30573670
    [TBL] [Abstract][Full Text] [Related]  

  • 29. CRISPR-Cas "Non-Target" Sites Inhibit On-Target Cutting Rates.
    Moreb EA; Hutmacher M; Lynch MD
    CRISPR J; 2020 Dec; 3(6):550-561. PubMed ID: 33346713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. RNA-Independent DNA Cleavage Activities of Cas9 and Cas12a.
    Sundaresan R; Parameshwaran HP; Yogesha SD; Keilbarth MW; Rajan R
    Cell Rep; 2017 Dec; 21(13):3728-3739. PubMed ID: 29281823
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Cas9, Cpf1 and C2c1/2/3-What's next?
    Nakade S; Yamamoto T; Sakuma T
    Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Single-Stranded DNA Cleavage by Divergent CRISPR-Cas9 Enzymes.
    Ma E; Harrington LB; O'Connell MR; Zhou K; Doudna JA
    Mol Cell; 2015 Nov; 60(3):398-407. PubMed ID: 26545076
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nucleosomes Inhibit Cas9 Endonuclease Activity in Vitro.
    Hinz JM; Laughery MF; Wyrick JJ
    Biochemistry; 2015 Dec; 54(48):7063-6. PubMed ID: 26579937
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular basis for the PAM expansion and fidelity enhancement of an evolved Cas9 nuclease.
    Chen W; Zhang H; Zhang Y; Wang Y; Gan J; Ji Q
    PLoS Biol; 2019 Oct; 17(10):e3000496. PubMed ID: 31603896
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evolved Cas9 variants with broad PAM compatibility and high DNA specificity.
    Hu JH; Miller SM; Geurts MH; Tang W; Chen L; Sun N; Zeina CM; Gao X; Rees HA; Lin Z; Liu DR
    Nature; 2018 Apr; 556(7699):57-63. PubMed ID: 29512652
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Guide RNA functional modules direct Cas9 activity and orthogonality.
    Briner AE; Donohoue PD; Gomaa AA; Selle K; Slorach EM; Nye CH; Haurwitz RE; Beisel CL; May AP; Barrangou R
    Mol Cell; 2014 Oct; 56(2):333-339. PubMed ID: 25373540
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Comparison of non-canonical PAMs for CRISPR/Cas9-mediated DNA cleavage in human cells.
    Zhang Y; Ge X; Yang F; Zhang L; Zheng J; Tan X; Jin ZB; Qu J; Gu F
    Sci Rep; 2014 Jun; 4():5405. PubMed ID: 24956376
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiplex genome engineering using CRISPR/Cas systems.
    Cong L; Ran FA; Cox D; Lin S; Barretto R; Habib N; Hsu PD; Wu X; Jiang W; Marraffini LA; Zhang F
    Science; 2013 Feb; 339(6121):819-23. PubMed ID: 23287718
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome engineering using CRISPR-Cas9 system.
    Cong L; Zhang F
    Methods Mol Biol; 2015; 1239():197-217. PubMed ID: 25408407
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expanding the Genome-Editing Toolbox with
    Nakamura A; Yamamoto H; Yano T; Hasegawa R; Makino Y; Mitsuda N; Terakawa T; Ito S; Sugano SS
    CRISPR J; 2024 Aug; 7(4):197-209. PubMed ID: 39111827
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 124.